Neuropsychiatric Disorders and COVID-19: What We Know So Far

dc.contributor.author	Laufer, Stefan
dc.date.accessioned	2022-01-31T08:05:25Z
dc.date.available	2022-01-31T08:05:25Z
dc.date.issued	2021
dc.identifier.issn	1424-8247
dc.identifier.uri	http://hdl.handle.net/10900/123657
dc.language.iso	en	de_DE
dc.publisher	Mdpi	de_DE
dc.relation.uri	http://dx.doi.org/10.3390/ph14090933	de_DE
dc.subject.ddc	540	de_DE
dc.subject.ddc	610	de_DE
dc.title	Neuropsychiatric Disorders and COVID-19: What We Know So Far	de_DE
dc.type	Article	de_DE
utue.quellen.id	20211125174918_00737
utue.personen.roh	Majolo, Fernanda
utue.personen.roh	da Silva, Guilherme Liberato
utue.personen.roh	Vieira, Lucas
utue.personen.roh	Anli, Cetin
utue.personen.roh	Timmers, Luis Fernando Saraiva Macedo
utue.personen.roh	Laufer, Stefan
utue.personen.roh	Goettert, Marcia Ines
dcterms.isPartOf.ZSTitelID	Pharmaceuticals	de_DE
dcterms.isPartOf.ZS-Issue	Article 933	de_DE
dcterms.isPartOf.ZS-Volume	14	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE
utue.fakultaet	07 Mathematisch-Naturwissenschaftliche Fakultät	de_DE